Life Sciences IP Review

Life Sciences IP Review Daily news and analysis for IP professionals in the life sciences.

Life Sciences IP Review is the leading online publication for IP professionals in the life sciences. With e-magazines covering the latest IP, regulatory and transactional matters in the fields of life sciences, as well as daily online news updates and weekly and monthly digital reports and virtual events, Life Sciences IP Review is the most comprehensive news and comment service for life sciences

IP professionals across the globe. Get the latest news and guidance on the challenges facing IP specialists in the life sciences, visit our website today: www.lifesciencesipreview.com.

Exciting news! J A Kemp is a Silver Sponsor for LSPN North America – Fall 2025.Join us on 21–22 October at the Hyatt Reg...
10/10/2025

Exciting news! J A Kemp is a Silver Sponsor for LSPN North America – Fall 2025.

Join us on 21–22 October at the Hyatt Regency, San Francisco, for the premier life sciences IP event of the year.

Reserve your spot now: https://ow.ly/mptK50X6482

We’re proud to have Haley Guiliano supporting LSPN North America – Fall 2025 as a Silver Sponsor!Experience two days of ...
10/10/2025

We’re proud to have Haley Guiliano supporting LSPN North America – Fall 2025 as a Silver Sponsor!

Experience two days of panels, case studies, and networking designed for life sciences IP professionals in San Francisco this October.

Sign up today: https://ow.ly/c88850X647r

Your colleagues are already registered. Are you?Momentum is building fast for LSPN Europe 2025—and this week alone we’ve...
10/10/2025

Your colleagues are already registered. Are you?

Momentum is building fast for LSPN Europe 2025—and this week alone we’ve confirmed attendees from Evotec, LifeArc, Oxford Biomedica, Astex Pharmaceuticals, Nuclera, Achilles Therapeutics, UK BioIndustry Association, and Sandoz.

We’ve also just added new speakers from AstraZeneca and Astellas, joining senior IP leaders from Regeneron, CureVac, Bicycle Therapeutics, Autolus, and more.

🗓 November 4, 2025
📍 London

In one day, we’ll cover the full spectrum of European life sciences IP strategy:
⚖️ UPC vs national courts: tactical venue selection
💊 EU pharmaceutical package implications
🧬 Patent cliff strategies & lifecycle management
🧠 Biosimilar competition & clearance tactics
🧪 Plausibility standards across therapeutics & MedTech

Prices increase at midnight — secure your seat now at the early rate: https://ow.ly/qmtS50X9BrY

Moore & Van Allen has strengthened its IP team by hiring Larry Rickles, a seasoned counsel with a decade of in-house pha...
09/10/2025

Moore & Van Allen has strengthened its IP team by hiring Larry Rickles, a seasoned counsel with a decade of in-house pharma experience at Teva and Johnson & Johnson.

Rickles brings deep expertise in managing global trademark, copyright, and domain portfolios across highly regulated industries.

Discover how his appointment elevates the firm’s IP capabilities: https://ow.ly/sTh250X9i4g

Teva in-house counsel jumps to private practice

AI and intellectual property took centre stage at C**A’s 2025 Congress in Bristol, exploring how emerging technologies a...
09/10/2025

AI and intellectual property took centre stage at C**A’s 2025 Congress in Bristol, exploring how emerging technologies are reshaping IP strategies worldwide.

Delegates discussed the promises and pitfalls of AI while reflecting on innovation’s evolution since Isambard Kingdom Brunel’s era.

Discover how AI is transforming the IP landscape: https://ow.ly/C1Jp50X9hZc

**ACongress

Bridging Brunel and AI: Why C**A sees ‘a golden opportunity’

A 2021 Supreme Court ruling shook up Brazil’s patent term extensions, forcing pharma companies to rethink IP strategies ...
09/10/2025

A 2021 Supreme Court ruling shook up Brazil’s patent term extensions, forcing pharma companies to rethink IP strategies and portfolio management.

Juliana Neves of Licks Attorneys outlines key changes, upcoming reforms, and practical steps for safeguarding patents.

Discover expert insights on navigating Brazil’s evolving pharma IP landscape: https://ow.ly/H4xt50X9hVB

Brazil’s patent shake-up: How pharma is handling a new reality

Gilead Sciences has secured more than a decade of extended market exclusivity for its blockbuster HIV drug Biktarvy afte...
09/10/2025

Gilead Sciences has secured more than a decade of extended market exclusivity for its blockbuster HIV drug Biktarvy after settling patent disputes with three generic challengers.

The move delays generic competition until at least 2033, protecting a key revenue driver.

Explore how this settlement reshapes the HIV treatment landscape: https://ow.ly/raxC50X9hS7

Gilead blocks HIV drug generics for more than 10 years

A warm welcome to DLA Piper, joining us as a Silver Sponsor at LSPN North America – Fall 2025!Don’t miss this opportunit...
09/10/2025

A warm welcome to DLA Piper, joining us as a Silver Sponsor at LSPN North America – Fall 2025!

Don’t miss this opportunity to learn from leading in-house and private practice IP professionals at the Hyatt Regency, San Francisco.

Register now: https://ow.ly/PXeJ50X646q

Thrilled to announce Birch, Stewart, Kolasch & Birch (BSKB) as a Silver Sponsor for LSPN North America – Fall 2025!Conne...
09/10/2025

Thrilled to announce Birch, Stewart, Kolasch & Birch (BSKB) as a Silver Sponsor for LSPN North America – Fall 2025!

Connect with top IP experts, discover the latest trends, and exchange ideas in life sciences patent law on 21–22 October in San Francisco.

Secure your spot here: https://ow.ly/q2w750X645W

We’re excited to welcome Akin as a Silver Sponsor for LSPN North America – Fall 2025, happening 21–22 October at the Hya...
08/10/2025

We’re excited to welcome Akin as a Silver Sponsor for LSPN North America – Fall 2025, happening 21–22 October at the Hyatt Regency, San Francisco!

Join us for two days of expert panels, networking, and insights from leading life sciences IP professionals.

📅 Register today: https://ow.ly/BVKe50X645w

We’re thrilled to have Sterne Kessler as a Gold Sponsor for LSPN North America – Fall 2025!Don’t miss two days of networ...
08/10/2025

We’re thrilled to have Sterne Kessler as a Gold Sponsor for LSPN North America – Fall 2025!

Don’t miss two days of networking, insights, and practical guidance for life sciences IP professionals in San Francisco this October.

Secure your place today: https://ow.ly/sQiv50X645h

Last chance to join LSPN North America–Fall!On October 21-22 in San Francisco, this premier life sciences IP event bring...
08/10/2025

Last chance to join LSPN North America–Fall!

On October 21-22 in San Francisco, this premier life sciences IP event brings together 50+ in-house patent counsel and legal experts from top biotech and pharmaceutical companies.

Recent registrations include Gilead Sciences, BridgeBio, Wolf Greenfield, Gladstone Institutes, Hoffmann Eitle, Arc Institute, Parker Institute, and new speakers from Philips and Sutro Biopharma.

Connect with Genentech, Amgen, Pfizer, Novartis, Johnson & Johnson, Illumina, and other industry leaders. Gain CLE credits, engage in high-impact panels, and network with 150+ peers shaping the future of biotech and pharma IP.

Only a handful of tickets left—secure your spot now! https://ow.ly/fULj50X8o78

Address

Kingfisher House, 21-23 Elmfield Road
Bromley
BR11LT

Opening Hours

Monday 9am - 5pm
Tuesday 9am - 5pm
Wednesday 9am - 5pm
Thursday 9am - 5pm
Friday 9am - 5am

Alerts

Be the first to know and let us send you an email when Life Sciences IP Review posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Life Sciences IP Review:

Share